The consortium comprises 52 private and public partners on 1 January 2020: 36 companies (from start-up to large company), 4 investors, 3 tech transfer partners and 9 public partners including the 3 administrative bodies of TWB (INRAE, INSA, CNRS). TWB partners share socio-economic objectives linked to industrial biotechnology and they take advantage of synergies within the network:
- Through the Strategic Steering Committee (SSC), they guarantee management of TWB defining orientations.
- They decide all self-funded research projects (pre-competitive projects), allowing economically and socially relevant technological innovations to be generated. In this task, the consortium is supported by a scientific committee and an ethics and sustainable development committee.
- They participate in the evaluation committees of research projects in progress, sharing immediate access to the results.
A consortium agreement binds TWB and all partners in order to simplify contract negotiations and lead very quickly to the implementation of collaborative projects. Simple rules of intellectual property have been predefined.